Suppr超能文献

粪便微生物群移植治疗严重食物不耐受的疗效:一例报告

Therapeutic efficacy of fecal microbiota transplantation in severe food intolerance: a case report.

作者信息

Huang Yanhui, Huang Jiayuan, Li Yuange, Xu Tianyu, Quan Guoqiao, Xu Peihao, Yang Xiaoya, Liu Zhou, Xie Wenrui

机构信息

Department of Gastroenterology, Research Center for Engineering Techniques of Microbiota-Targeted Therapies of Guangdong, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.

School of Clinical Medicine, Guangdong Medical University, Zhanjiang, China.

出版信息

Front Nutr. 2025 May 19;12:1594022. doi: 10.3389/fnut.2025.1594022. eCollection 2025.

Abstract

This report presents the first documented application of fecal microbiota transplantation (FMT) for the management of extensive multi-food intolerance involving 52 specific foods in a pediatric patient with autism spectrum disorder (ASD). A 7 years-old autistic child was diagnosed with food intolerance to 52 items, presenting with generalized rashes, diarrhea, and malnutrition (BMI of 12.9) upon exposure or ingestion of the implicated foods. The child received oral fecal microbiota capsule treatment, with a daily dose of nine capsules (a total of 120 capsules per course) for two consecutive treatment courses. The rashes resolved, the child regained tolerance to previously intolerable foods, nutritional status improved, and stool consistency normalized. This case suggests that FMT may hold therapeutic potential for managing food intolerance in autistic patients.

摘要

本报告介绍了首次有文献记载的粪便微生物群移植(FMT)用于治疗一名患有自闭症谱系障碍(ASD)的儿科患者广泛的多种食物不耐受,该患者对52种特定食物不耐受。一名7岁的自闭症儿童被诊断出对52种食物不耐受,在接触或摄入相关食物后出现全身性皮疹、腹泻和营养不良(体重指数为12.9)。该儿童接受了口服粪便微生物群胶囊治疗,每日剂量为9粒胶囊(每个疗程共120粒胶囊),连续进行两个疗程的治疗。皮疹消退,该儿童恢复了对以前不耐受食物的耐受性,营养状况改善,大便性状恢复正常。该病例表明,FMT可能对治疗自闭症患者的食物不耐受具有治疗潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6de/12127135/cf7aea5aff6a/fnut-12-1594022-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验